Options: Show MedDRA Preferred Terms, display all 37 labels
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cardiac failure | x | |||||||||||||||||||||
| Cerebrovascular accident | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||
| Cough | x | x | ||||||||||||||||||||
| Diabetic | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||
| Diabetic nephropathy | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||||
| Essential hypertension | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||
| Hypersensitivity | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||
| Hypertension | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||
| Hypertensive | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||
| Left ventricular hypertrophy | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||
| Myocardial infarction | x | |||||||||||||||||||||
| Nephropathy | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||||
| Proteinuria | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||||
| Renal failure chronic | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||
| Type 2 diabetes mellitus | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |